title: Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy.
abstract: Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.
authors.affiliation: Hospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, Brazil.
authors.forename: Luiz Carlos
authors.initials: LC
authors.lastname: Porcello Marrone
authors.forename: Bianca Fontana
authors.initials: BF
authors.lastname: Marrone
authors.forename: Tharick Ali
authors.initials: TA
authors.lastname: Pascoal
authors.forename: Lucas Porcello
authors.initials: LP
authors.lastname: Schilling
authors.forename: Ricardo Bernardi
authors.initials: RB
authors.lastname: Soder
authors.forename: Sheila Schuch
authors.initials: SS
authors.lastname: Ferreira
authors.forename: Giovani
authors.initials: G
authors.lastname: Gadonski
authors.forename: Jaderson Costa
authors.initials: JC
authors.lastname: da Costa